MedPath

Vachapippali nasya in migraine

Phase 2/3
Not yet recruiting
Conditions
Other specified disorders of nervous system in diseases classified elsewhere. Ayurveda Condition: ARDHAVABEDAKAH,
Registration Number
CTRI/2023/09/057304
Lead Sponsor
Dr Aishwarya Adhikrao Metkari
Brief Summary

the most common neurovascular headache which constitutes 16% ofthe primary headache and affects 10-20% that is 14.5% of the generalpopulation. the ratio of women and men is 3:1 In Ayurveda has mentioned nasya therapy as the master key forall urdhavajatrugat vyadhi and need of effective treatment forArdhavbhedak.All shirorogas are due to tridosha prakopa and chiefly due tovata or vata-kapha .Thus, Ardhavabhedak can be best managed withAushadhis having ushna, snigdha, properties. Thus vachapippali yogain the form of nasya which is having vatakaphhar properties has beenselected as shodhan therapy in the present study. To evaluate Vachapippali Avapid nasya given in 6 Bindu/nostrils for 7 daysonce day in the morning is significantly effective in the managementof Ardhavbhedak .. Patient will be taken from the shalakyatantra OPD and IPDPatient will be selected simple Random sampling technique by Lotterymethod on the basis of Inclusion criteria of assessment. Informed written consent will be taken. Sample size 84 patient are taken. Group A(trial group) 42 patient Vachapippali Avapid nasya given given in 6 Bindu/ nostrils for 7 days OD in morning  and Group B(control group) 42 patient Sitopalamadanphala Avapid nasya given givenin 6 Bindu/ nostrils for 7 days OD in morning .Treatment duration will be 7days for both group and follow upOn 14th, 21st day. Assessment will be done on the basis ofimprovement in symptoms of patients before and after thetreatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
84
Inclusion Criteria
  • patient diagnosed with Ardhavbhedak ( migraine) with following symptoms 2.
  • Ardhashirashoola , Hrullas, Prakashasahatva, Shabdasahatva, Chhardi 3.
  • Patient between the age group 18-50 year Irrespective Gender, Religion, Occupation, Socioeconomic status will be selected simple Random sampling technique by Lottery method for the study 4.
  • Patient with chronicity more than three months 5.
  • Nasyaharya.
Exclusion Criteria
  • Migraine with aura 2.
  • Patient with depression and psychological disorders 3.
  • Referred pain due to any other disorders 4.
  • Head injury or any brain lesions 5.
  • Trigeminal neuralgia 6.
  • Metabolic and systemic disorders causing headache 7.
  • Pregnancy migraine 8.
  • Menstrual migraine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Vachapippali Avapid Nasya in7 Days
Ardhavbhedak with special reference to migraine7 Days
Secondary Outcome Measures
NameTimeMethod
1. To compare the efficacy of Vachapippali Avapid nasya withSitopalamadanphala Avapid nasya in Ardhavbhedak

Trial Locations

Locations (1)

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta

🇮🇳

Sangli, MAHARASHTRA, India

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta
🇮🇳Sangli, MAHARASHTRA, India
Dr Aishwarya Adhikrao Metkari
Principal investigator
7888288141
aishwaryametkari23@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.